Theriva Biologics, Inc. Preferred Stock, Par or Stated Value Per Share
Theriva Biologics, Inc. (TOVX) had Preferred Stock, Par or Stated Value Per Share of $1000.00 per share as of 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Balance Sheet › Equity
us-gaap:PreferredStockParOrStatedValuePerShare · last filed 2023-03-30
- 2021-12-31: Preferred Stock, Par or Stated Value Per Share $1000.00.
- 2021-09-30: Preferred Stock, Par or Stated Value Per Share $1000.00.
- 2021-06-30: Preferred Stock, Par or Stated Value Per Share $1000.00.
- 2021-03-31: Preferred Stock, Par or Stated Value Per Share $1000.00.
| Period end | Preferred Stock, Par or Stated Value Per Share | Preferred Stock, Par or Stated Value Per Share as first filed |
|---|---|---|
| 2021-12-31 | $1000.00 10-K · filed 2022-03-16 | |
| 2021-09-30 | $1000.00 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $1000.00 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $1000.00 10-Q · filed 2021-05-05 | |
| 2020-12-31 | $1000.00 10-K · filed 2022-03-16 | $0.00 10-K · filed 2021-03-04 |
| 2020-11-16 | $0.00 10-K · filed 2023-03-30 | |
| 2020-09-30 | $1000.00 10-Q · filed 2020-11-10 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-04 | $1000.00 10-Q · filed 2020-11-10 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-03 | |
| 2017-03-31 | $0.00 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $0.00 10-Q · filed 2017-08-03 | |
| 2016-09-30 | $0.00 10-Q · filed 2016-11-01 | |
| 2016-06-30 | $0.00 10-Q · filed 2016-08-03 | |
| 2016-03-31 | $0.00 10-Q · filed 2016-05-05 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-02 | |
| 2015-09-30 | $0.00 10-Q · filed 2015-11-05 | |
| 2015-06-30 | $0.00 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-10 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $0.00 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $0.00 10-K · filed 2015-03-16 | |
| 2013-09-30 | $0.00 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $0.00 10-K · filed 2014-03-31 | |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $0.00 10-Q/A · filed 2012-09-11 | |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $0.00 10-K · filed 2013-04-16 | |
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $0.00 10-K/A · filed 2012-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |